{
  "results": [
    {
      "test_case_id": "standard_001",
      "query": "What's my cholesterol trend over my entire data? I want to see trends across the top 4 cholesterol metrics including Triglycerides across that time period",
      "success": true,
      "total_response_time_ms": 67095.05,
      "tokens_used": 471,
      "error_message": null,
      "expected_complexity": "STANDARD",
      "actual_complexity": "standard",
      "complexity_correct": true,
      "expected_specialties": "{'data_analysis', 'endocrinology', 'cardiology'}",
      "actual_specialties": "{'data_analysis', 'laboratory_medicine', 'cardiology'}",
      "specialty_precision": 0.5,
      "specialty_recall": 0.5,
      "specialty_f1": 0.5,
      "analysis_quality_score": 0.7599999999999999,
      "quality_breakdown": {
        "data_gathering": 1.0,
        "context_awareness": 0.7,
        "specialist_rationale": 0.7,
        "comprehensive_approach": 0.7,
        "concern_identification": 0.7
      },
      "tool_calls_made": 2,
      "tool_success_rate": 1.0,
      "tool_relevance_score": 1.0,
      "response_valid": true,
      "structure_errors": [],
      "approach_text": "To analyze the patient's cholesterol trends over time, we should:\n\n- Focus on pulling data for the 4 key cholesterol metrics: \n1) Total Cholesterol\n2) LDL Cholesterol \n3) HDL Cholesterol\n4) Triglycerides\n- Ensure we have data points for those 4 metrics spanning the patient's entire available history\n- Determine the specific date range of available data for each metric\n- Investigate any major changes or inflection points in the levels over time\n- Check if values are within normal/healthy ranges for the patient's demographics \n- Explore correlations between the 4 metrics - e.g. inverse relationship between HDL and LDL\n- Consider calculating the total cholesterol/HDL ratio over time as a key heart health indicator\n- Look into any significant gaps in data that may skew long-term trends\n- Assess overall cardiovascular risk based on the cholesterol trends and levels\n\nPriority should be on establishing a clear data set for the 4 key metrics over the full timeframe, then analyzing long-term trends and changes for each, and finally exploring metric inter-relationships and overall heart health implications. Presenting the data as a longitudinal visualization will be valuable.",
      "initial_data_gathered": {
        "summary": "The patient has a good amount of cholesterol lab data over a 12 year period from 2013-2025, including total cholesterol, LDL, and HDL values. This should allow for trend analysis of those key metrics over time. \n\nHowever, triglyceride results were not found in this initial query. Additional searching may be needed to determine if triglyceride data is available to include in the full analysis.\n\nThe presence of numeric values and dates will enable graphing the trends over time. Reference ranges are available for some results to provide context.",
        "tool_calls_made": 0
      },
      "analysis_time_ms": 36678.376,
      "specialist_tasks": [
        {
          "specialist": "laboratory_medicine",
          "objective": "Retrieve all total cholesterol, LDL, HDL, and triglyceride lab values with dates from 2013 to present to establish complete data set for trend analysis",
          "context": "Initial data shows total cholesterol, LDL, and HDL values from 2013-2025, but triglyceride data is missing. Need complete data for all 4 metrics over full 12 year period for thorough trend analysis.",
          "expected_output": "Comprehensive data set including total cholesterol, LDL, HDL, and triglyceride numeric values with dates spanning 2013 to 2025",
          "priority": 1,
          "max_tool_calls": 5
        },
        {
          "specialist": "data_analysis",
          "objective": "Analyze trends in total cholesterol, LDL, HDL and triglycerides over time, identifying major changes, inflection points, and correlations between the 4 metrics",
          "context": "With the full 12-year data set from laboratory_medicine, we can now assess long-term trends and changes in the 4 key cholesterol metrics. Exploring relationships between them, like the typical inverse...",
          "expected_output": "Longitudinal analysis of each cholesterol metric over time, highlighting significant changes, trends, and inter-metric correlations. Calculation of total cholesterol/HDL ratio trend as a key indicator.",
          "priority": 2,
          "max_tool_calls": 5
        },
        {
          "specialist": "cardiology",
          "objective": "Evaluate overall cardiovascular risk based on the patient's cholesterol trends and levels compared to normal ranges, considering age and gender",
          "context": "With the trends and correlations identified by data_analysis, cardiology can now interpret those cholesterol patterns in terms of the patient's heart health and risk factors. The longitudinal total ch...",
          "expected_output": "Assessment of the patient's cardiovascular risk over time based on their comprehensive cholesterol data, including concrete risk category (low/medium/high). Identification of time periods of higher or lower risk and potential contributing factors.",
          "priority": 3,
          "max_tool_calls": 5
        }
      ],
      "task_creation_success": true,
      "task_creation_time_ms": 30416.249,
      "task_creation_error": null,
      "task_count": 3,
      "task_quality_score": 0.8666666666666667,
      "task_quality_breakdown": {
        "completeness": 1.0,
        "specificity": 0.6666666666666666,
        "diversity": 1.0
      },
      "approach_mentioned_specialties": "set()",
      "key_data_points": [
        "hdl_cholesterol",
        "ldl_cholesterol",
        "total_cholesterol",
        "triglycerides",
        "trends",
        "date_range"
      ],
      "specialist_analysis": {
        "prompt_file": "backend/services/agents/cmo/prompts/3_assign_specialist_tasks.txt",
        "issue_description": "The task creation prompt did not adequately capture the need for an endocrinology specialist when analyzing cholesterol trends and metrics related to metabolic disorders.",
        "missing_specialists_reason": {
          "endocrinology": "Endocrinologists specialize in hormonal conditions and metabolic disorders like cholesterol and lipid abnormalities. Their expertise is critical for interpreting cholesterol trends, correlations between metrics, and assessing overall cardiovascular risk."
        },
        "unnecessary_specialists": [],
        "specific_changes": [
          "Add guidance: 'When the query mentions analyzing trends in cholesterol or lipid markers, always include the endocrinology specialist'",
          "Clarify in prompt: 'Consider the role of specialists in metabolic disorders and hormonal regulation when selecting relevant experts for cholesterol/lipid analysis'"
        ],
        "reasoning": "These changes will ensure that the endocrinology specialist is automatically included for queries related to cholesterol trends and analysis. Their expertise in metabolic disorders and lipid regulation is essential for interpreting cholesterol metrics, assessing cardiovascular risk, and providing comprehensive recommendations. The prompt currently lacks explicit guidance on considering metabolic factors when selecting specialists for cholesterol-related queries.",
        "priority": "high"
      },
      "quality_analysis": {
        "quality_issues": [
          "Analysis quality below threshold (0.76 < 0.80)"
        ],
        "medical_accuracy": "Failed to comprehensively address all key data points",
        "completeness": "Missing coverage of some medical concepts",
        "clinical_appropriateness": "Adequate but could be more comprehensive",
        "recommendations": [
          "Add instruction: 'Ensure all key medical concepts mentioned in the query are addressed'",
          "Add guidance: 'Provide more comprehensive analysis covering all relevant data points'"
        ],
        "priority": "medium"
      }
    },
    {
      "test_case_id": "standard_002",
      "query": "Show my abnormal lab results from labs this year?",
      "success": true,
      "total_response_time_ms": 83306.172,
      "tokens_used": 496,
      "error_message": null,
      "expected_complexity": "STANDARD",
      "actual_complexity": "standard",
      "complexity_correct": true,
      "expected_specialties": "{'laboratory_medicine', 'endocrinology', 'preventive_medicine'}",
      "actual_specialties": "{'laboratory_medicine', 'endocrinology', 'general_practice'}",
      "specialty_precision": 0.5,
      "specialty_recall": 0.5,
      "specialty_f1": 0.5,
      "analysis_quality_score": 0.7599999999999999,
      "quality_breakdown": {
        "data_gathering": 1.0,
        "context_awareness": 0.7,
        "specialist_rationale": 0.7,
        "comprehensive_approach": 0.7,
        "concern_identification": 0.7
      },
      "tool_calls_made": 2,
      "tool_success_rate": 1.0,
      "tool_relevance_score": 1.0,
      "response_valid": true,
      "structure_errors": [],
      "approach_text": "To analyze the patient's abnormal lab results from 2023, I recommend the following approach:\n\nKey data points to investigate:\n- Focus on tests with abnormal flags or results outside reference ranges\n- Glucose, HbA1c, liver enzymes (AST, ALT), and BUN appear elevated on certain dates and warrant further review\n- Evaluate how far outside the normal range abnormal values are\n\nCorrelations to explore:\n- Look for patterns or trends in the abnormal results over time \n- Check if abnormalities in different tests occur together (e.g. AST/ALT, glucose/HbA1c)\n- Note which abnormalities repeat across multiple dates\n\nHealth concerns to consider:\n- Elevated glucose and HbA1c could indicate diabetes or prediabetes\n- High liver enzymes may signal liver inflammation or damage\n- Elevated BUN could relate to kidney function or hydration status\n\nTimeframes and cadence:\n- Abnormal tests are scattered from January to November, so look across the full 11 months \n- Check for any clusters of abnormal results around particular dates\n- Compare earlier to later results to identify any worsening or improvement\n\nPriority and focus areas:\n- Glucose/HbA1c and liver enzymes appear to be the most frequent abnormalities, so prioritize investigating those\n- The abnormal BUN result was more isolated, so is lower priority \n- If time allows, briefly scan other results for any other tests in the abnormal range",
      "initial_data_gathered": {
        "summary": "The query results provide a good overview of the patient's lab results from 2023. Key findings:\n- There are 353 lab results spanning multiple providers from January to November 2023\n- Tests cover a wide range of areas including metabolic panels, blood counts, lipids, inflammatory markers, and more\n- A few abnormal results are noted, such as elevated glucose, HbA1c, AST, and BUN on some dates\n- Most results appear to be in the normal range\n- The data should be sufficient to identify any significantly abnormal lab values from 2023, though additional queries may be needed to get more specifics on certain tests or dates",
        "tool_calls_made": 0
      },
      "analysis_time_ms": 51552.504,
      "specialist_tasks": [
        {
          "specialist": "laboratory_medicine",
          "objective": "Identify all lab tests with abnormal results from January to November 2023, focusing on glucose, HbA1c, liver enzymes, and BUN. Retrieve the actual numeric values for each abnormal result.",
          "context": "The patient's 2023 labs show elevated glucose, HbA1c, AST, ALT and BUN on certain dates. We need the specific abnormal values to assess how far outside the normal range they are.",
          "expected_output": "A list of all abnormal lab results in 2023 with test name, date, abnormal value, and reference range for each.",
          "priority": 1,
          "max_tool_calls": 5
        },
        {
          "specialist": "endocrinology",
          "objective": "Analyze the patient's 2023 glucose and HbA1c trends to assess for diabetes or prediabetes. Determine if values are worsening, improving or stable over the 11 months.",
          "context": "The patient had abnormal glucose and HbA1c results on multiple dates in 2023, which could indicate diabetes or prediabetes. We need to look at the overall trend of these values.",
          "expected_output": "An assessment of whether the glucose and A1c trends are consistent with diabetes, prediabetes, or neither. Note any significant changes in values from early to late 2023.",
          "priority": 2,
          "max_tool_calls": 5
        },
        {
          "specialist": "general_practice",
          "objective": "Review the patient's abnormal liver and kidney results from 2023 to determine if additional evaluation is needed for those organ systems.",
          "context": "Elevated liver enzymes (AST, ALT) and BUN were noted on some 2023 lab reports. While not the most frequent abnormalities, these still warrant a general assessment.",
          "expected_output": "A recommendation on whether the abnormal AST, ALT and BUN results require further workup such as imaging or referral to a specialist. Note if any are potentially clinically significant.",
          "priority": 3,
          "max_tool_calls": 5
        }
      ],
      "task_creation_success": true,
      "task_creation_time_ms": 31753.145,
      "task_creation_error": null,
      "task_count": 3,
      "task_quality_score": 0.7333333333333334,
      "task_quality_breakdown": {
        "completeness": 1.0,
        "specificity": 0.3333333333333333,
        "diversity": 1.0
      },
      "approach_mentioned_specialties": "set()",
      "key_data_points": [
        "lab_results",
        "abnormal_flags",
        "current_year",
        "reference_ranges"
      ],
      "specialist_analysis": {
        "prompt_file": "backend/services/agents/cmo/prompts/3_assign_specialist_tasks.txt",
        "issue_description": "The prompt did not properly account for queries related to abnormal lab results, leading to missing the preventive_medicine specialist and including an unnecessary general_practice specialist.",
        "missing_specialists_reason": {
          "preventive_medicine": "Abnormal lab results often warrant preventive care to catch potential health issues early, so this specialist should have been included."
        },
        "unnecessary_specialists": [
          "general_practice"
        ],
        "specific_changes": [
          "Add guidance: 'When the query mentions abnormal lab results, always include the preventive_medicine specialist'",
          "Clarify in prompt: 'Focus on preventive care and screening needs when abnormal results are mentioned'"
        ],
        "reasoning": "By explicitly accounting for abnormal lab result queries and their preventive care implications, the prompt will better capture the need for preventive_medicine expertise. Removing general_practice avoids an overly broad specialist inclusion. These changes will lead to more accurate specialist teams tailored to abnormal lab result cases.",
        "priority": "high"
      },
      "quality_analysis": {
        "quality_issues": [
          "Analysis quality below threshold (0.76 < 0.80)"
        ],
        "medical_accuracy": "Failed to comprehensively address all key data points",
        "completeness": "Missing coverage of some medical concepts",
        "clinical_appropriateness": "Adequate but could be more comprehensive",
        "recommendations": [
          "Add instruction: 'Ensure all key medical concepts mentioned in the query are addressed'",
          "Add guidance: 'Provide more comprehensive analysis covering all relevant data points'"
        ],
        "priority": "medium"
      }
    },
    {
      "test_case_id": "complex_001",
      "query": "Analyze cholesterol relevant medication adherence patterns over that time period and how do they correlate with these cholesterol lab results.",
      "success": true,
      "total_response_time_ms": 91310.70300000001,
      "tokens_used": 580,
      "error_message": null,
      "expected_complexity": "COMPLEX",
      "actual_complexity": "complex",
      "complexity_correct": true,
      "expected_specialties": "{'laboratory_medicine', 'data_analysis', 'cardiology', 'pharmacy', 'endocrinology'}",
      "actual_specialties": "{'laboratory_medicine', 'data_analysis', 'general_practice', 'cardiology', 'pharmacy'}",
      "specialty_precision": 0.6666666666666666,
      "specialty_recall": 0.6666666666666666,
      "specialty_f1": 0.6666666666666666,
      "analysis_quality_score": 0.7599999999999999,
      "quality_breakdown": {
        "data_gathering": 1.0,
        "context_awareness": 0.7,
        "specialist_rationale": 0.7,
        "comprehensive_approach": 0.7,
        "concern_identification": 0.7
      },
      "tool_calls_made": 2,
      "tool_success_rate": 1.0,
      "tool_relevance_score": 1.0,
      "response_valid": true,
      "structure_errors": [],
      "approach_text": "To analyze cholesterol medication adherence patterns and correlations with lab results, I recommend:\n\nData points to investigate:\n- Cholesterol medication start/stop dates, dosage changes over time\n- Cholesterol lab values (total, LDL, HDL) and dates to align with medication timeline\n- Look for patterns of lab values before and after medication changes\n\nCorrelations to explore:\n- Impact of starting, stopping, or changing medication dosage on subsequent lab results \n- Timeframe between a medication change and seeing effects in lab values\n- Differences in effects between medication types (statins vs other classes)\n\nHealth concerns to address:\n- Periods of high LDL or low HDL levels and relation to medication adherence\n- Instances of cholesterol levels above recommended range despite treatment\n- Identifying any significant gaps in medication adherence\n\nTimeframes to consider:\n- Changes within 3, 6, 12 months after starting or changing a medication\n- Longer-term trends in cholesterol levels over multiple years\n\nFocus areas:\n- Effectiveness of different medication regimens in controlling cholesterol\n- Patient's response to medication changes (positive or negative)\n- Consistency of medication usage and correlation with cholesterol control\n\nPriorities:\n1. Align medication and lab data points into a unified timeline \n2. Identify key medication changes and analyze subsequent lab trends\n3. Assess overall adherence patterns and long-term cholesterol management\n4. Determine any concerning time periods with suboptimal cholesterol control",
      "initial_data_gathered": {
        "summary": "The data available includes:\n- Cholesterol medication records (rosuvastatin, ezetimibe, atorvastatin) with dosage information spanning 2013-2025\n- Cholesterol lab results (total, LDL, HDL) with numeric values spanning 2013-2025\n- Sufficient data points over time to analyze trends and correlations between medication adherence and lab results\n- Will require complex analysis to align medication and lab data points temporally and look for patterns/relationships",
        "tool_calls_made": 0
      },
      "analysis_time_ms": 47795.263,
      "specialist_tasks": [
        {
          "specialist": "pharmacy",
          "objective": "Analyze cholesterol medication adherence patterns from 2013-2025, identifying any significant gaps or changes in dosage/frequency",
          "context": "Patient has records of rosuvastatin, ezetimibe, atorvastatin usage with dosage information from 2013-2025. Look for periods of inconsistent use or extended gaps in treatment.",
          "expected_output": "Timeline of cholesterol medication adherence with annotations for key changes, gaps, or dosage adjustments",
          "priority": 1,
          "max_tool_calls": 7
        },
        {
          "specialist": "laboratory_medicine",
          "objective": "Retrieve all cholesterol lab results (Total, LDL, HDL) from 2013-2025 to analyze in context of medication timeline",
          "context": "Cholesterol lab data with numeric values is available from 2013-2025. Pull the complete set of results to align with pharmacy data for adherence analysis.",
          "expected_output": "Complete dataset of cholesterol lab results (Total, LDL, HDL values with dates) from 2013 through most recent test",
          "priority": 2,
          "max_tool_calls": 7
        },
        {
          "specialist": "data_analysis",
          "objective": "Analyze correlations between cholesterol medication adherence/changes and subsequent cholesterol lab results over 3, 6, and 12 month intervals",
          "context": "With pharmacy and lab data, look for patterns in how starting, stopping, or changing cholesterol meds impacts lab results. Determine average timeframe to see effects.",
          "expected_output": "Statistical analysis of medication adherence effects on cholesterol levels, including average lab changes 3, 6, 12 months after key medication events",
          "priority": 3,
          "max_tool_calls": 7
        },
        {
          "specialist": "cardiology",
          "objective": "Assess periods of heightened cardiovascular risk based on suboptimal cholesterol levels and medication adherence",
          "context": "Review combined medication and lab data to identify periods of LDL above 160 or HDL below 40 and determine if correlated with medication adherence gaps.",
          "expected_output": "Timeline annotating periods of increased CV risk based on high LDL, low HDL and medication usage patterns, with total duration quantified",
          "priority": 4,
          "max_tool_calls": 7
        },
        {
          "specialist": "general_practice",
          "objective": "Summarize overall long-term trends in cholesterol management and identify areas for improvement in treatment plan adherence",
          "context": "Review holistic data analysis to assess trajectory of cholesterol health and management over the 12 year history. Determine if current regimen is optimal.",
          "expected_output": "Narrative summary of long-term cholesterol management, including successful strategies, problem areas, and recommendations for improved adherence",
          "priority": 5,
          "max_tool_calls": 7
        }
      ],
      "task_creation_success": true,
      "task_creation_time_ms": 43514.736,
      "task_creation_error": null,
      "task_count": 5,
      "task_quality_score": 0.9200000000000002,
      "task_quality_breakdown": {
        "completeness": 1.0,
        "specificity": 0.8,
        "diversity": 1.0
      },
      "approach_mentioned_specialties": "set()",
      "key_data_points": [
        "statin_history",
        "medication_switches",
        "ldl_correlation",
        "hdl_patterns",
        "triglyceride_response",
        "adherence_gaps"
      ],
      "specialist_analysis": {
        "prompt_file": "backend/services/agents/cmo/prompts/3_assign_specialist_tasks.txt",
        "issue_description": "The prompt did not explicitly cover correlating medication adherence patterns with lab results, leading to the omission of the endocrinology specialist.",
        "missing_specialists_reason": {
          "endocrinology": "Endocrinologists specialize in hormonal conditions like diabetes and metabolic disorders, which are closely tied to cholesterol management and interpretation of related lab results."
        },
        "unnecessary_specialists": [
          "general_practice"
        ],
        "specific_changes": [
          "Add guidance: 'When query involves correlating medication usage patterns with lab results, include the endocrinology specialist'",
          "Clarify in prompt: 'Consider conditions impacting medication metabolism and absorption when selecting specialists, as this may require additional specialties like endocrinology'"
        ],
        "reasoning": "These changes will help the prompt explicitly account for endocrinology expertise when medication adherence and lab result correlation is a key part of the query. This will prevent overlooking this critical specialty. Additionally, removing the general practice specialist makes sense as the query is fairly specialized.",
        "priority": "high"
      },
      "quality_analysis": {
        "quality_issues": [
          "Analysis quality below threshold (0.76 < 0.80)"
        ],
        "medical_accuracy": "Failed to comprehensively address all key data points",
        "completeness": "Missing coverage of some medical concepts",
        "clinical_appropriateness": "Adequate but could be more comprehensive",
        "recommendations": [
          "Add instruction: 'Ensure all key medical concepts mentioned in the query are addressed'",
          "Add guidance: 'Provide more comprehensive analysis covering all relevant data points'"
        ],
        "priority": "medium"
      }
    },
    {
      "test_case_id": "complex_002",
      "query": "How has my HbA1c level changed since I started taking metformin, has my dosage been adjusted over time based on my lab results, and is there a correlation between these changes and my weight measurements during the same period?",
      "success": false,
      "total_response_time_ms": 73751.49799999999,
      "tokens_used": 545,
      "error_message": null,
      "expected_complexity": "COMPLEX",
      "actual_complexity": "standard",
      "complexity_correct": false,
      "expected_specialties": "{'nutrition', 'endocrinology', 'pharmacy'}",
      "actual_specialties": "{'data_analysis', 'laboratory_medicine', 'endocrinology'}",
      "specialty_precision": 0.2,
      "specialty_recall": 0.2,
      "specialty_f1": 0.20000000000000004,
      "analysis_quality_score": 0.7599999999999999,
      "quality_breakdown": {
        "data_gathering": 1.0,
        "context_awareness": 0.7,
        "specialist_rationale": 0.7,
        "comprehensive_approach": 0.7,
        "concern_identification": 0.7
      },
      "tool_calls_made": 2,
      "tool_success_rate": 1.0,
      "tool_relevance_score": 1.0,
      "response_valid": true,
      "structure_errors": [],
      "approach_text": "To address this patient's question about how metformin has impacted their HbA1c levels and weight over time, I recommend the following analytical approach:\n\nKey data points to investigate:\n- HbA1c lab values and dates to assess glycemic control over time\n- Metformin prescription details, specifically dosage, to identify any changes \n- Weight measurements and dates to track changes in body weight\n- Align all data points along a timeline based on the dates\n\nCorrelations to explore:\n- Changes in HbA1c in relation to metformin start date and any dosage adjustments\n- Relationship between HbA1c levels and weight measurements over time\n- Impact of any significant weight changes on HbA1c and vice versa\n\nHealth concerns to consider:  \n- Glycemic control as measured by HbA1c and whether it remains in goal range\n- Magnitude and trajectory of any changes in HbA1c and weight\n- Potential need for adjustment to diabetes management plan\n\nTimeframes and focus areas:\n- Analyze full duration of available data during metformin treatment (2021 to 2025)\n- Pay special attention to timepoints surrounding metformin initiation and dosage changes\n- Compare pre-metformin baseline data, if available, to on-treatment values\n- Assess most recent values to determine current status\n\nPrioritize the HbA1c and metformin data as the primary focus, with weight as a key secondary factor to investigate in relation to glycemic control. The analysis should aim to clearly elucidate the patient's HbA1c trend, evaluate the impact of metformin, and identify any clinically relevant correlations with weight to inform treatment recommendations.",
      "initial_data_gathered": {
        "summary": "The query returned data on HbA1c lab results, metformin prescriptions with dosage details, and weight measurements over the time period the patient has been taking metformin (June 2021 to present). \n\nKey observations:\n- Metformin was first prescribed in June 2021 at a 500mg dose. The dosage has remained consistent at 500mg.\n- There are 3 HbA1c results available during the metformin treatment period, showing values of 5.7% (Feb 2023), 5.9% (Jun 2023), and 6.1% (Apr 2025). This suggests an upward trend.\n- Weight measurements are available at various timepoints and show fluctuations between 192-226 lbs.\n\nThe available data should allow analyzing trends in HbA1c and weight over time in relation to the metformin therapy. Correlations may be possible but the limited number of HbA1c datapoints may impact the strength of conclusions. Overall this is a standard complexity query that is feasible with the retrieved data.",
        "tool_calls_made": 0
      },
      "analysis_time_ms": 49578.86,
      "specialist_tasks": [
        {
          "specialist": "endocrinology",
          "objective": "Analyze the patient's HbA1c trend over time in relation to their metformin therapy, identifying any changes in glycemic control and evaluating current diabetes management status.",
          "context": "The patient started metformin 500mg in June 2021 and has remained on this dose. HbA1c values show an upward trend from 5.7% in Feb 2023 to 6.1% in Apr 2025, suggesting potentially worsening glycemic c...",
          "expected_output": "A report detailing the patient's HbA1c trend with specific values and dates, interpretation of glycemic control status, and assessment of current diabetes management effectiveness.",
          "priority": 1,
          "max_tool_calls": 5
        },
        {
          "specialist": "laboratory_medicine",
          "objective": "Retrieve and organize all relevant lab data, including HbA1c results with specific values and dates, to support analysis of glycemic control and correlation with other factors.",
          "context": "The initial data shows 3 HbA1c results from 2023-2025. Additional historical results are needed to analyze the full trend during metformin treatment.",
          "expected_output": "A comprehensive dataset of the patient's HbA1c lab results, including test dates, numeric values, and reference ranges, covering the entire period from metformin start in 2021 to present.",
          "priority": 2,
          "max_tool_calls": 5
        },
        {
          "specialist": "data_analysis",
          "objective": "Investigate potential correlations between the patient's HbA1c levels, metformin therapy, and weight measurements over time, identifying any clinically significant relationships.",
          "context": "The available data includes HbA1c results, consistent metformin dosage, and weight measurements showing some fluctuations. Aligning these factors along a timeline can help identify correlations.",
          "expected_output": "A report analyzing statistical correlations and trends between HbA1c, metformin treatment, and weight, highlighting any significant findings that could impact clinical management decisions.",
          "priority": 3,
          "max_tool_calls": 5
        }
      ],
      "task_creation_success": true,
      "task_creation_time_ms": 24172.017,
      "task_creation_error": null,
      "task_count": 3,
      "task_quality_score": 0.7333333333333334,
      "task_quality_breakdown": {
        "completeness": 1.0,
        "specificity": 0.3333333333333333,
        "diversity": 1.0
      },
      "approach_mentioned_specialties": "set()",
      "key_data_points": [
        "hba1c_trend",
        "metformin_initiation",
        "dose_adjustments",
        "weight_correlation",
        "glycemic_control",
        "temporal_analysis"
      ],
      "complexity_analysis": {
        "root_cause": "Failed to analyze complexity mismatch",
        "complexity_indicators": [
          "Review complexity classification criteria"
        ],
        "medical_context": "Automated analysis failed",
        "recommendations": [
          "Review complexity classification criteria"
        ],
        "priority": "medium"
      },
      "specialist_analysis": {
        "prompt_file": "backend/services/agents/cmo/prompts/3_assign_specialist_tasks.txt",
        "issue_description": "The prompt failed to identify nutrition and pharmacy as critical specialists for analyzing correlations between metformin, HbA1c levels, and weight changes over time.",
        "missing_specialists_reason": {
          "nutrition": "The query specifically asks about weight measurements, which requires input from a nutrition specialist to interpret trends and provide dietary recommendations based on the analysis.",
          "pharmacy": "As the query focuses on metformin dosage adjustments and their impact, a pharmacy specialist should be involved to review prescription details and provide guidance on medication management."
        },
        "unnecessary_specialists": [
          "data_analysis",
          "laboratory_medicine"
        ],
        "specific_changes": [
          "Add guidance: 'When query mentions medication dosage changes, include pharmacy specialist'",
          "Add guidance: 'When query asks about weight or nutrition factors, include nutrition specialist'",
          "Clarify in prompt: 'Consider medication management and dietary factors when selecting specialists for queries involving treatment impact on lab results'"
        ],
        "reasoning": "These changes will help the prompt better identify when pharmacy and nutrition expertise is required based on key details in the query. Removing data analysis and laboratory medicine specialists is appropriate since the primary need is interpreting clinical data rather than performing the analysis itself or laboratory procedures. The clarified prompt guidance ensures medication management and dietary factors are given proper consideration when selecting relevant specialists for treatment effect queries.",
        "priority": "high"
      },
      "quality_analysis": {
        "quality_issues": [
          "Analysis quality below threshold (0.76 < 0.80)"
        ],
        "medical_accuracy": "Failed to comprehensively address all key data points",
        "completeness": "Missing coverage of some medical concepts",
        "clinical_appropriateness": "Adequate but could be more comprehensive",
        "recommendations": [
          "Add instruction: 'Ensure all key medical concepts mentioned in the query are addressed'",
          "Add guidance: 'Provide more comprehensive analysis covering all relevant data points'"
        ],
        "priority": "medium"
      }
    }
  ],
  "aggregated": {
    "total_tests": 4,
    "successful_tests": 3,
    "success_rate": 0.75,
    "average_response_time_ms": 78865.85575,
    "total_tokens_used": 2092,
    "average_tokens_per_test": 523.0,
    "failed_tests": [
      "complex_002"
    ]
  },
  "summary": {
    "overall_success": false,
    "success_rate": 0.75,
    "total_tests": 4,
    "failed_tests": [
      "complex_002"
    ],
    "performance_metrics": {
      "avg_response_time_ms": 78865.85575,
      "avg_tokens_per_test": 523.0
    }
  },
  "overall_success": false,
  "timestamp": "2025-07-15T16:55:41.740884",
  "test_count": 4,
  "agent_type": "cmo",
  "test_type": "real-world",
  "category": null
}